Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,852 | -70,780 | -29,965 | -112,747 | -76,161 |
| Depreciation Amortization | 7,522 | 4,452 | 1,604 | 2,590 | 1,449 |
| Accounts payable and accrued liabilities | 415 | 4,810 | 3,282 | 2,208 | 1,396 |
| Other Working Capital | 104,581 | 165,077 | -14,916 | 232,723 | 262,281 |
| Other Operating Activity | 43,687 | 28,578 | 13,295 | 50,338 | 33,450 |
| Operating Cash Flow | $68,353 | $132,137 | $-26,700 | $175,112 | $222,415 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,240 | -8,223 | -3,378 | -11,747 | -7,494 |
| Purchase Of Investment | -493,066 | -391,498 | -153,736 | -902,128 | -629,403 |
| Sale Of Investment | 451,466 | 344,000 | 210,000 | 655,000 | 420,000 |
| Other Investing Activity | 0 | 0 | 0 | 15 | 15 |
| Investing Cash Flow | $-49,840 | $-55,721 | $52,886 | $-258,860 | $-216,882 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,512 | 19,925 | 7,582 | 59,572 | 48,538 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -104 |
| Other Financing Activity | -2,036 | -1,898 | -1,424 | -149 | -34 |
| Financing Cash Flow | $20,476 | $18,027 | $6,158 | $59,423 | $48,400 |
| Beginning Cash Position | 132,385 | 132,385 | 132,385 | 156,710 | 156,710 |
| End Cash Position | 171,374 | 226,828 | 164,729 | 132,385 | 210,643 |
| Net Cash Flow | $38,989 | $94,443 | $32,344 | $-24,325 | $53,933 |
| Free Cash Flow | |||||
| Operating Cash Flow | 68,353 | 132,137 | -26,700 | 175,112 | 222,415 |
| Capital Expenditure | -8,240 | -8,223 | -3,378 | -11,747 | -7,494 |
| Free Cash Flow | 60,113 | 123,914 | -30,078 | 163,365 | 214,921 |